NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/08/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13,485 mln
Float55.41 mln
Earnings Date06/02/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
0.11
Very low leverage
ROE
-54.33
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Regencell Bioscience Holdings Limited is a Hong Kong-based company dedicated to advancing Traditional Chinese Medicine as a modern treatment option. Founded in 2014 and based in Causeway Bay, the company applies scientific research to develop and bring to market remedies targeting brain and cognitive conditions, with a particular focus on ADHD and autism spectrum disorder.
